A phase II trial of ZD0473 in platinum-pretreated ovarian cancerGORE, M. E; ATKINSON, R. J; THOMAS, H et al.European journal of cancer (1990). 2002, Vol 38, Num 18, pp 2416-2420, issn 0959-8049, 5 p.Article

A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignanciesTWELVES, Chris; RECK, Martin; ANTHONEY, Alan et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 4, pp 277-281, issn 0344-5704, 5 p.Article

A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Trial, IND 129GELMON, K. A; VANDENBERG, T. A; PANASCI, L et al.Annals of oncology. 2003, Vol 14, Num 4, pp 543-548, issn 0923-7534, 6 p.Article

ZD0473 pharmacokinetics in Japanese patients: a Phase I dose-escalation studyMURAKAMI, H; TAMURA, T; YAMADA, Y et al.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 8, pp S1-S5, issn 1359-6349Article